ATE319427T1 - Zusammensetzungen zur anwendung von entzündungshemmenden, insbesondere antiseptischen und/oder wundheilenden wirkstoffen im oberen atemwegtrakt und/oder ohr - Google Patents

Zusammensetzungen zur anwendung von entzündungshemmenden, insbesondere antiseptischen und/oder wundheilenden wirkstoffen im oberen atemwegtrakt und/oder ohr

Info

Publication number
ATE319427T1
ATE319427T1 AT99926446T AT99926446T ATE319427T1 AT E319427 T1 ATE319427 T1 AT E319427T1 AT 99926446 T AT99926446 T AT 99926446T AT 99926446 T AT99926446 T AT 99926446T AT E319427 T1 ATE319427 T1 AT E319427T1
Authority
AT
Austria
Prior art keywords
respiratory tract
ear
wound
compositions
active ingredients
Prior art date
Application number
AT99926446T
Other languages
English (en)
Inventor
Wolfgang Fleischer
Karen Reimer
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Application granted granted Critical
Publication of ATE319427T1 publication Critical patent/ATE319427T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Virology (AREA)
  • Otolaryngology (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Anesthesiology (AREA)
  • Rheumatology (AREA)
  • AIDS & HIV (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Materials For Medical Uses (AREA)
AT99926446T 1998-05-27 1999-05-27 Zusammensetzungen zur anwendung von entzündungshemmenden, insbesondere antiseptischen und/oder wundheilenden wirkstoffen im oberen atemwegtrakt und/oder ohr ATE319427T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8689598P 1998-05-27 1998-05-27

Publications (1)

Publication Number Publication Date
ATE319427T1 true ATE319427T1 (de) 2006-03-15

Family

ID=22201600

Family Applications (3)

Application Number Title Priority Date Filing Date
AT99953285T ATE235895T1 (de) 1998-05-27 1999-05-27 Arzneistoff-abgabesystem enthaltend eine festgepackte, feste arzneistoffbasis
AT99926446T ATE319427T1 (de) 1998-05-27 1999-05-27 Zusammensetzungen zur anwendung von entzündungshemmenden, insbesondere antiseptischen und/oder wundheilenden wirkstoffen im oberen atemwegtrakt und/oder ohr
AT99926448T ATE339187T1 (de) 1998-05-27 1999-05-27 Verwendung von zusammensetzungen mit antiseptika und/oder die wundheilung fördernden wirkstoffen für den tieferen atemwegstrakt

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT99953285T ATE235895T1 (de) 1998-05-27 1999-05-27 Arzneistoff-abgabesystem enthaltend eine festgepackte, feste arzneistoffbasis

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT99926448T ATE339187T1 (de) 1998-05-27 1999-05-27 Verwendung von zusammensetzungen mit antiseptika und/oder die wundheilung fördernden wirkstoffen für den tieferen atemwegstrakt

Country Status (19)

Country Link
US (2) US20080038330A1 (de)
EP (3) EP1079806B1 (de)
JP (3) JP4741727B2 (de)
KR (3) KR100445146B1 (de)
CN (3) CN1303272A (de)
AT (3) ATE235895T1 (de)
AU (3) AU759264B2 (de)
BR (3) BR9911072A (de)
CA (3) CA2332369A1 (de)
CY (1) CY1105834T1 (de)
DE (6) DE29923848U1 (de)
DK (2) DK1079806T3 (de)
ES (2) ES2273493T3 (de)
HK (2) HK1035335A1 (de)
HU (3) HUP0102892A3 (de)
IL (4) IL139229A0 (de)
PT (2) PT1079807E (de)
RU (3) RU2211693C2 (de)
WO (3) WO1999061003A1 (de)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7297344B1 (en) 1999-05-27 2007-11-20 Euro-Celtique, S.A. Preparations for the promotion of wound healing in the upper respiratory tract and/or ear
JP4937453B2 (ja) * 1999-05-27 2012-05-23 ユーロ−セルティック エス． ア． 抗感染剤および／または抗炎症剤を適用するための製剤
US7300667B1 (en) 1999-05-27 2007-11-27 Euro-Celtique, S.A. Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract
DE20022718U1 (de) * 1999-05-27 2002-04-04 Euroceltique S.A., Luxemburg/Luxembourg Formulierungen zur Anwendung von entzündungshemmenden Mitteln
JP2003522144A (ja) * 2000-02-08 2003-07-22 ユーロ−セルティーク，エス．エイ． オピオイドアゴニストおよびアンタゴニストを含む制御放出組成物
US6989157B2 (en) * 2000-07-27 2006-01-24 Nucryst Pharmaceuticals Corp. Dry powders of metal-containing compounds
JP2004517127A (ja) 2000-12-21 2004-06-10 ネクター セラピューティックス ポリエン抗真菌剤の肺送達
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
DE10125731A1 (de) * 2001-05-17 2003-03-06 A I D Autoimmun Diagnostika Gm Darreichungsform von immunologischen Wirkstoffen
DE10141650C1 (de) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
WO2003077891A1 (fr) * 2002-03-18 2003-09-25 Yamanouchi Pharmaceutical Co., Ltd. Compositions medicales en poudre pour inhalation et procede de production de celles-ci
US7718189B2 (en) 2002-10-29 2010-05-18 Transave, Inc. Sustained release of antiinfectives
EP1561467A4 (de) * 2002-11-11 2008-06-25 Kowa Co Zusammensetzung zur wiederherstellung geschädigter haut
US20040133099A1 (en) 2002-12-18 2004-07-08 Dyer R. Kent Otologic nanotechnology
EP1449520A1 (de) * 2003-02-24 2004-08-25 Euro-Celtique S.A. Verwendung von PVP-Jod zur Behandlung von Herpes
DK1479379T3 (da) * 2003-05-19 2008-01-02 Euro Celtique Sa Törre, liposomale PVP-iod-sammensætninger
US8651113B2 (en) 2003-06-18 2014-02-18 Swr&D Inc. Magnetically responsive nanoparticle therapeutic constructs and methods of making and using
US7723311B2 (en) 2003-06-18 2010-05-25 Nanobiomagnetics, Inc. Delivery of bioactive substances to target cells
US7344491B1 (en) 2003-11-26 2008-03-18 Nanobiomagnetics, Inc. Method and apparatus for improving hearing
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
US20050058673A1 (en) 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
US9028852B2 (en) 2004-09-07 2015-05-12 3M Innovative Properties Company Cationic antiseptic compositions and methods of use
FR2878746B1 (fr) 2004-12-02 2007-02-23 Vetoquinol Sa Sa Nouvelle composition pharmaceutique utilisable dans le domaine des vaccins
WO2006099359A2 (en) 2005-03-10 2006-09-21 3M Innovative Properties Company Methods of reducing microbial contamination
KR20070113281A (ko) 2005-03-10 2007-11-28 쓰리엠 이노베이티브 프로퍼티즈 컴파니 항미생물성 조성물 및 방법
HUE029994T2 (en) 2005-12-08 2017-04-28 Insmed Inc Lipid-based preparations of antinfectants for the treatment of lung infections
DE102006011314A1 (de) 2006-03-11 2007-10-18 Peter Dr. Engels Kosmetische Zubereitungen mit einem Zusatz aus der Baobab-Pflanze
US20080057129A1 (en) * 2006-04-03 2008-03-06 Lerner E I Drug microparticles
RU2315593C1 (ru) * 2006-08-02 2008-01-27 Открытое Акционерное Общество Завод Экологической Техники И Экопитания "Диод" Липосомальная композиция антиоксидантов для ингаляций при заболеваниях легких и верхних дыхательных путей
US8071127B2 (en) 2006-10-24 2011-12-06 Aradigm Corporation Dual action, inhaled formulations providing both an immediate and sustained release profile
US8268347B1 (en) * 2006-10-24 2012-09-18 Aradigm Corporation Dual action, inhaled formulations providing both an immediate and sustained release profile
US8119156B2 (en) * 2006-10-24 2012-02-21 Aradigm Corporation Dual action, inhaled formulations providing both an immediate and sustained release profile
US8338491B2 (en) 2006-10-27 2012-12-25 3M Innovative Properties Company Antimicrobial compositions
US20100196455A1 (en) 2007-05-04 2010-08-05 Transave, Inc. Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof
US9333214B2 (en) 2007-05-07 2016-05-10 Insmed Incorporated Method for treating pulmonary disorders with liposomal amikacin formulations
US9119783B2 (en) 2007-05-07 2015-09-01 Insmed Incorporated Method of treating pulmonary disorders with liposomal amikacin formulations
US9114081B2 (en) 2007-05-07 2015-08-25 Insmed Incorporated Methods of treating pulmonary disorders with liposomal amikacin formulations
WO2009067067A1 (en) * 2007-11-23 2009-05-28 Pharmalundensis Ab Method and means for obtaining bronchorelaxation
WO2009085651A1 (en) 2007-12-20 2009-07-09 Nucryst Pharmaceuticals Corp. Metal carbonate particles for use in medicine and methods of making thereof
KR20100048751A (ko) * 2008-10-31 2010-05-11 주식회사 동성바이오레인 스프레이 가능한 캡슐화된 기능성 미립자 조성물과 그 제조방법
NL2002442C2 (nl) 2009-01-22 2010-07-26 Weezenbeek Specialties B V Van Werkwijze voor het verjongen van een bitumen bevattende samenstelling.
EP2226073A1 (de) 2009-03-02 2010-09-08 Euro-Celtique S.A. Topische pharmazeutische Zusammensetzungen enthaltend ein Antiseptikum und Arginin zur Wundheilung
US20110086084A1 (en) * 2009-10-13 2011-04-14 David William Koenig Active Agent Containing Polymer Network Delivery Composition and Articles Using the Same
EP2722053B1 (de) 2010-12-30 2017-10-25 Aktsionernoye Obshchestvo "Nauchnyi Tsentr Protivoinfektsionnyh Preparatov" Antibakterielles mittel zur behandlung von infektionskrankheiten bakteriellen ursprungs
WO2013059622A1 (en) * 2011-10-19 2013-04-25 President And Fellows Of Harvard College Treatments for mycobacterium tuberculosis
KR101860485B1 (ko) * 2011-11-03 2018-07-02 (주)아모레퍼시픽 미세 유화 입자를 포함하는 미용 티슈, 그 제조방법 및 사용방법
US20150272880A1 (en) * 2012-05-21 2015-10-01 Insmed Incorporated Systems for treating pulmonary infections
BR112015012351A8 (pt) 2012-11-29 2019-10-01 Insmed Inc composição de antibiótico de glicopeptídeo à base de lipídeo estabilizado e uso de um componente lipídico, um componente de antibiótico de glicopeptídeo e um aminoácido ou derivado do mesmo
RU2538433C1 (ru) * 2013-06-11 2015-01-10 Закрытое акционерное общество "ФИРН М" (ЗАО ФИРН М") Фармацевтическая композиция для профилактики и лечения инфекционно-воспалительных заболеваний различной этиологии путем оромукозного введения
US9987227B2 (en) 2013-10-22 2018-06-05 Aradigm Corporation Inhaled surfactant-modified liposomal formulations providing both an immediate and sustained release profile
RU2550932C1 (ru) * 2014-03-18 2015-05-20 Александр Александрович Кролевец Способ получения нанокапсул цефалоспориновых антибиотиков в ксантановой камеди
CN107072944B (zh) 2014-04-08 2021-11-02 阿拉迪姆公司 具有抗非结核分枝杆菌活性的脂质体环丙沙星制剂
US20160120806A1 (en) * 2014-04-08 2016-05-05 Aradigm Corporation Nanocrystals formed in a microenvironment
KR20160144404A (ko) * 2014-04-08 2016-12-16 아라다임 코포레이션 냉동-해동 후 약물 나노결정을 형성하는 리포솜
PL3142643T3 (pl) 2014-05-15 2019-12-31 Insmed Incorporated Sposoby leczenia zakażeń płuc prątkami niegruźliczymi
HUE056533T2 (hu) 2014-07-23 2022-02-28 Firebrick Pharma Ltd Közönséges megfázás kezelése és megelõzése povidon-jód alkalmazásával
KR102086150B1 (ko) 2017-04-10 2020-03-06 부산대학교 산학협력단 하이드로겔화 되는 창상 치료용 파우더 조성물 및 이의 제조방법
FR3066115B1 (fr) 2017-05-10 2019-06-28 Universite de Bordeaux Comprimes de vecteurs d'acides nucleiques
JP6955784B2 (ja) * 2017-07-04 2021-10-27 フルケム リミテッドＦｌｕｃｈｅｍ Ｌｔｄ 水溶解性が向上されたヨード剤及び塩化ナトリウムを含む固体組成物及びその水溶液を含む目、口腔用、鼻腔用又は吸入用抗ウイルス及び抗菌組成物
WO2019009630A1 (ko) * 2017-07-04 2019-01-10 김대황 수용해성이 향상된 요오드제 및 염화나트륨을 포함하는 고체 조성물 및 이의 수용액을 포함하는 눈, 구강용, 비강용 또는 흡입용 항바이러스 및 항균 조성물
KR101935250B1 (ko) * 2017-07-04 2019-01-04 김대황 요오드제 및 삼투성 미각제를 포함하는 눈, 구강용, 비강용 또는 흡입용 항바이러스 및 항균 조성물
KR102026805B1 (ko) 2017-12-12 2019-11-04 주식회사 크로파세 항염 화장료 조성물
JP7460534B2 (ja) 2018-03-30 2024-04-02 インスメッド インコーポレイテッド リポソーム医薬品の連続製造方法
US20210121432A1 (en) * 2018-04-17 2021-04-29 Université De Caen Normandie Bambuterol for the Treatment of Alzheimer's Disease
RU2730834C1 (ru) * 2020-01-17 2020-08-26 Александр Александрович Кролевец Способ получения нанокапсул тимола
KR102244368B1 (ko) * 2020-03-30 2021-04-27 현대바이오사이언스 주식회사 비타민과 덱스판테놀이 봉입된 에토좀 조성물 및 이의 제조방법
CN111700883B (zh) * 2020-07-23 2021-04-06 深圳大佛药业股份有限公司 一种硫酸沙丁胺醇缓释型吸入制剂及其生产工艺
JP2022151438A (ja) * 2021-03-26 2022-10-07 均 石井 外耳炎と中耳炎と内耳炎の治療薬。
JP2022151426A (ja) * 2021-03-26 2022-10-07 均 石井 上気道炎治療薬。

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE615889A (de) * 1952-04-15 1900-01-01
US4113857A (en) * 1977-05-16 1978-09-12 The Purdue Frederick Company Process for the preparation of iodophor compounds and methods for stabilizing iodophor pharmaceutical compositions containing the same
US4675009A (en) * 1977-11-07 1987-06-23 Lec Tec Corporation Drug dispensing device for transdermal delivery of medicaments
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
FR2536278A1 (fr) * 1982-11-18 1984-05-25 Dupont Michele Nouvelle composition therapeutique utile notamment pour la cicatrisation des plaies
US4704383A (en) * 1983-12-29 1987-11-03 The Research Foundation Of State University Of New York Non-antibacterial tetracycline compositions possessing anti-collagenolytic properties and methods of preparing and using same
FR2581542B1 (fr) * 1985-05-07 1988-02-19 Oreal Compositions topiques destinees au traitement de la peau a base de derives de l'acide salicylique
FR2591105B1 (fr) * 1985-12-11 1989-03-24 Moet Hennessy Rech Composition pharmaceutique, notamment dermatologique, ou cosmetique, a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un retinoide ou un analogue structural dudit retinoide tel qu'un carotenoide.
SE8603812D0 (sv) * 1986-09-12 1986-09-12 Draco Ab Administration of liposomes to mammals
US5049388A (en) * 1986-11-06 1991-09-17 Research Development Foundation Small particle aerosol liposome and liposome-drug combinations for medical use
US4938965A (en) * 1987-07-22 1990-07-03 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of National Defence Of Her Majesty's Canadian Government Ocular delivery of prophylactic agents
US5246708A (en) * 1987-10-28 1993-09-21 Pro-Neuron, Inc. Methods for promoting wound healing with deoxyribonucleosides
DE3826946C1 (de) * 1988-08-09 1990-03-15 A. Nattermann & Cie Gmbh, 5000 Koeln, De
US4906476A (en) * 1988-12-14 1990-03-06 Liposome Technology, Inc. Novel liposome composition for sustained release of steroidal drugs in lungs
US5006343A (en) * 1988-12-29 1991-04-09 Benson Bradley J Pulmonary administration of pharmaceutically active substances
US5232692A (en) * 1989-04-28 1993-08-03 Research And Education Institute, Inc. Povidone-iodine neonatal ophthalmic antimicrobial prophylactic agent
EP0407028B2 (de) * 1989-05-31 1999-07-07 FISONS plc Medikament und Inhalationsvorrichtung dafür
US5089389A (en) * 1989-08-25 1992-02-18 Eastman Kodak Company Buffered composition, coated article test device and a method for their use
US5128139A (en) * 1991-02-15 1992-07-07 Nu Skin International, Inc. Composition containing liposome-entrapped grapefruit seed extract and method for making
DE4111982C2 (de) * 1991-04-12 1998-12-24 Merz & Co Gmbh & Co Stabile kleinpartikuläre Liposomenzubereitungen, deren Herstellung und Verwendung
AU1537292A (en) * 1991-04-16 1992-11-17 Nippon Shinyaku Co. Ltd. Method of manufacturing solid dispersion
ATE221379T1 (de) * 1991-05-01 2002-08-15 Jackson H M Found Military Med Verfahren zur behandlung infektiöser respiratorischer erkrankungen
AU4066693A (en) * 1992-12-23 1994-07-19 Bernhard Hugemann Compacted drug body for use in the mechanical generation of inhalable active-substance particles
US5552158A (en) * 1993-02-23 1996-09-03 Norac Technologies Inc. Skin care composition
DE4306475A1 (de) * 1993-03-02 1994-09-08 Ensenat Pedro Gonzalez Liposomen, enthaltend Chlorhexidindiacetat oder Chlorhexidindigluconat
WO1994028876A1 (en) * 1993-06-07 1994-12-22 Advanced Therapies, Inc. Liposome powders
US5512269A (en) * 1993-06-09 1996-04-30 Burroughs Wellcome, Co. Method of treating retained pulmonary secretions
US5456904A (en) * 1993-06-28 1995-10-10 The Procter & Gamble Company Photoprotection compositions comprising certain chelating agents
US5863556A (en) * 1993-08-20 1999-01-26 Euro-Celtique, S.A. Preparations for the external application of antiseptic agents and/or agents promoting the healing of wounds
DE9312509U1 (de) * 1993-08-20 1993-10-28 Euro-Celtique S.A., Luxemburg/Luxembourg Präparate zur äußeren Verabreichung von antiseptischen und/oder die Wundheilung fördernden Wirkstoffen
BR9509590A (pt) * 1994-11-04 1997-12-23 Polymun Scient Immunbio Forsch Aplicação de sod em liposomas
US5744457A (en) * 1995-03-31 1998-04-28 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
JPH08301774A (ja) * 1995-05-08 1996-11-19 Kowa Co 喉用殺菌消毒薬
EP1013269A4 (de) * 1997-06-06 2002-02-20 Shionogi & Co Verbesserung eines systems zur verabreichung von medikamenten
DE20022718U1 (de) * 1999-05-27 2002-04-04 Euroceltique S.A., Luxemburg/Luxembourg Formulierungen zur Anwendung von entzündungshemmenden Mitteln
JP4937453B2 (ja) * 1999-05-27 2012-05-23 ユーロ−セルティック エス． ア． 抗感染剤および／または抗炎症剤を適用するための製剤
US7297344B1 (en) * 1999-05-27 2007-11-20 Euro-Celtique, S.A. Preparations for the promotion of wound healing in the upper respiratory tract and/or ear
US7300667B1 (en) * 1999-05-27 2007-11-27 Euro-Celtique, S.A. Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract
US6497896B2 (en) * 2001-02-12 2002-12-24 Supergen, Inc. Method for administering camptothecins via injection of a pharmaceutical composition comprising microdroplets containing a camptothecin
DK1479379T3 (da) * 2003-05-19 2008-01-02 Euro Celtique Sa Törre, liposomale PVP-iod-sammensætninger
WO2011008987A2 (en) * 2009-07-15 2011-01-20 Regents Of The University Of Minnesota Treatment and placement device for sinusitis applications

Also Published As

Publication number Publication date
WO1999060998A1 (en) 1999-12-02
CA2332369A1 (en) 1999-12-02
HUP0102337A3 (en) 2002-12-28
CY1105834T1 (el) 2011-02-02
HUP0102892A2 (hu) 2002-03-28
ATE235895T1 (de) 2003-04-15
PT1079807E (pt) 2007-01-31
AU759264B2 (en) 2003-04-10
EP1079807B1 (de) 2006-09-13
EP1083886A1 (de) 2001-03-21
EP1083886B1 (de) 2003-04-02
KR100613706B1 (ko) 2006-08-21
JP4741727B2 (ja) 2011-08-10
JP2002516265A (ja) 2002-06-04
JP4741726B2 (ja) 2011-08-10
HUP0102337A2 (hu) 2002-03-28
IL139231A0 (en) 2001-11-25
JP2002516269A (ja) 2002-06-04
AU4370499A (en) 1999-12-13
RU2211693C2 (ru) 2003-09-10
AU747877B2 (en) 2002-05-30
BR9911070A (pt) 2001-02-06
ES2260915T3 (es) 2006-11-01
HUP0102899A3 (en) 2002-12-28
IL139230A (en) 2007-07-24
AU752018B2 (en) 2002-09-05
DE29923847U1 (de) 2001-04-12
RU2202340C2 (ru) 2003-04-20
HU226710B1 (en) 2009-07-28
HUP0102892A3 (en) 2002-12-28
DE29923766U1 (de) 2001-06-07
CA2332389C (en) 2008-09-09
DE69933208D1 (de) 2006-10-26
DE69906518D1 (de) 2003-05-08
PT1079806E (pt) 2006-06-30
HUP0102899A2 (hu) 2002-03-28
AU752018C (en) 2003-10-09
KR20010043820A (ko) 2001-05-25
AU4370699A (en) 1999-12-13
HK1035336A1 (en) 2001-11-23
IL139229A0 (en) 2001-11-25
CA2332371A1 (en) 1999-12-02
WO1999060999A1 (en) 1999-12-02
DK1079806T3 (da) 2006-07-17
EP1079807A1 (de) 2001-03-07
KR20010043821A (ko) 2001-05-25
CA2332389A1 (en) 1999-12-02
DE29923848U1 (de) 2001-04-12
HK1035335A1 (en) 2001-11-23
HU226729B1 (en) 2009-08-28
DK1079807T3 (da) 2007-01-22
EP1079806B1 (de) 2006-03-08
DE69930259D1 (de) 2006-05-04
IL139230A0 (en) 2001-11-25
WO1999061003A1 (en) 1999-12-02
RU2212884C2 (ru) 2003-09-27
KR100445146B1 (ko) 2004-08-18
US20120009253A1 (en) 2012-01-12
KR20010043819A (ko) 2001-05-25
CN1303276A (zh) 2001-07-11
CN1303272A (zh) 2001-07-11
ES2273493T3 (es) 2007-05-01
US20080038330A1 (en) 2008-02-14
DE69933208T2 (de) 2007-08-30
JP2002516266A (ja) 2002-06-04
EP1079806A1 (de) 2001-03-07
CN1303271A (zh) 2001-07-11
ATE339187T1 (de) 2006-10-15
BR9911072A (pt) 2001-02-06
AU4266799A (en) 1999-12-13
DE69930259T2 (de) 2006-11-23
BR9911071A (pt) 2001-02-06

Similar Documents

Publication Publication Date Title
ATE319427T1 (de) Zusammensetzungen zur anwendung von entzündungshemmenden, insbesondere antiseptischen und/oder wundheilenden wirkstoffen im oberen atemwegtrakt und/oder ohr
BRPI9908182B8 (pt) composições de proteína de matriz para cura de feridas
WO2002087563A3 (en) Compositions comprising an anti-microtubule agent and a polypeptide or a polysaccharide and the use thereof for the preparation of a medicament for the treatment of inflammatory conditions
DE60120648D1 (de) Formulierungen von copolymer 1 (glatirameracetat) zur oralen, nasalen und pulmonalen verabreichung
WO2001030802A3 (en) Therapeutic treatments comprising administration of certain steroids for blood cell deficiencies
HUP0101710A2 (hu) Mátrix-protein kompozíciók sebgyógyulás elősegítésére
UA35567C2 (uk) Фармацевтичний препарат для лікування хворих з порушеннями функції коагуляції, спосіб лікування таких хворих, спосіб одержання фармацевтичного препарату
DE50114474D1 (de) Kombination eines transdermalen therapeutischen systems und einer oralen und/oder parenteralen zubereitung enthaltend dopaminagonisten zur behandlung dopaminerger erkrankungen
ATE318610T1 (de) Orale zusammensetzungen zur behandlung von kopfhauterkrankungen
DE60031016D1 (de) Verwendung von Antiseptika zur Herstellung von Arzneimitteln zur Prophylaxe und Behandlung von Entzündungen im Korperinneren des Menschen
ATE458471T1 (de) Formulierungen mit povidon-iod zur behandlung von wunden
DK1343472T3 (da) Thixotropisk næsespray
ATE309803T1 (de) Sphingomyelinase inhibitoren als wirkstoffe mit antiapoptotischer und antiseptischer wirkung
HUP0204180A2 (hu) Külsőleges készítmény és alkalmazása allergiás dermatitisz kezelésére
BR0016646A (pt) Método para tratar um paciente que sofre de dor, e, composição farmacêutica
ATE284696T1 (de) Pharmazeutische zusammensetzung enthaltend salmeterol und budesonid zur behandlung von atemkrankheiten
CN111700825A (zh) 一种口腔健康护理用的油性组合物、其制备方法及其应用
JPS58219111A (ja) 薬剤
UA42335A (uk) Спосіб лікування гнійних ран
BR0205625C1 (pt) Formulações nasais em gel

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1079806

Country of ref document: EP